A non-interventional study to characterise patients with moderate RA

  • Research type

    Research Study

  • Full title

    A study to describe the direct healthcare resource utilisation, health-related quality of life and work productivity of patients with moderate RA

  • IRAS ID

    244291

  • Contact name

    Zoe Cole

  • Contact email

    Zoe.Cole@salisbury.nhs.uk

  • Sponsor organisation

    AbbVie Ltd UK

  • Duration of Study in the UK

    0 years, 7 months, 31 days

  • Research summary

    This is a multi-centre, non-interventional study in the UK. The study will be conducted in patients diagnosed with moderate Rheumatoid Arthritis (RA). RA is a long-term condition that causes pain, swelling and stiffness in the joints causing fatigue, disability, depression and decreased work productivity.

    There are two components of the study:
    1) data collection on patient demographics, clinical details, treatments for RA and hospital resource use via retrospective chart review for a minimum of 12 months, and a maximum of 24 months prior to study enrolment.
    2) completion of a series of patient and caregiver questionnaires at a single point in time.

    The study will take place in the rheumatology departments of 4-6 hospitals in the UK. It is anticipated that approximately 150 patients will be included in the retrospective chart review and, allowing for non-completion, 125 patient questionnaires and 50 caregiver questionnaires will be completed. A maximum of 50 patients will be selected from a single centre.

  • REC name

    North West - Liverpool Central Research Ethics Committee

  • REC reference

    18/NW/0286

  • Date of REC Opinion

    11 Apr 2018

  • REC opinion

    Favourable Opinion